Sandbox Reserved 693
From Proteopedia
(Difference between revisions)
Line 4: | Line 4: | ||
'''6-Mercaptopurine activity and targeting''' <br> | '''6-Mercaptopurine activity and targeting''' <br> | ||
- | [[Image:Mercaptopurine.png]] | ||
- | <Structure load='1hmp' size='500' frame='true' align='right' caption='GMP bound to HGPRT' scene='Insert optional scene name here' /> | + | <Structure load='1hmp' size='500' frame='true' align='right' caption='GMP bound to HGPRT' scene='Insert optional scene name here' /> |
+ | [[Image:Mercaptopurine.png]] | ||
6-Mercaptopurine (6-MP) is an anti-cancer drug used for decades to treat acute lymphoblastic leukemia, and in recent years for other conditions such as inflammatory bowel disease. | 6-Mercaptopurine (6-MP) is an anti-cancer drug used for decades to treat acute lymphoblastic leukemia, and in recent years for other conditions such as inflammatory bowel disease. |
Revision as of 21:17, 28 April 2013
This Sandbox is Reserved from 30/01/2013, through 30/12/2013 for use in the course "Biochemistry II" taught by Hannah Tims at the Messiah College. This reservation includes Sandbox Reserved 686 through Sandbox Reserved 700. |
To get started:
More help: Help:Editing |
6-Mercaptopurine activity and targeting
|
6-Mercaptopurine (6-MP) is an anti-cancer drug used for decades to treat acute lymphoblastic leukemia, and in recent years for other conditions such as inflammatory bowel disease.
3ns1 - 6mp bound to bovine xanthine oxidase 2bzg - TPMT